Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. The most advantageous
Sirolimus and tacrolimus are the major immunosuppressants for renal transplantation. Several studies have compared these 2 drugs, but the outcomes were not consistent. The aim of this study was to evaluate the efficacy, safety, and pharmacoeconomics of sirolimus and tacrolimus in the treatment of re
Drugs acting on immunophilins Ciclosporin Tacrolimus Sirolimus Everolimus Zotarolimus.
Drugs acting on immunophilins Ciclosporin Tacrolimus Sirolimus Everolimus Zotarolimus.
or ritonavir), or any other components of the product. If signs sirolimus. Effect on Concentration. ↑ cyclosporine. ↑ tacrolimus. ↑ everolimus. ↑ sirolimus.
Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. The most advantageous
Thirty-four patients (68%) in the sirolimus group vs three (6%) in the tacrolimus group needed definitive withdrawal of the study drug. Despite noninferiority of sirolimus compared to tacrolimus for kidney and pancreas graft survival, the high rate of sirolimus discontinuation does not favor its use as cornerstone therapy after SPK
sirolimus 3 to 5 months post-transplant (sirolimus group) or remained on cyclosporine (including Gengraf, Neoral, Sandimmune) or tacrolimus (Prograf) or
Sitagliptin Added to Tacrolimus/Sirolimus Prophylaxis Regimen for Acute Graft-vs-Host Disease After HSCT The incidence of grade 3 or 4 graft-
then vs than
accept vs expect
alright vs all right
its vs it's
there vs their
waist vs waste
your vs you're, you are